Literature DB >> 2006259

Corporate-sponsored breast cancer screening at the work site: results of a statewide program.

H B Kessler1, B K Rimer, P J Devine, R A Gatenby, P F Engstrom.   

Abstract

Mobile screening mammography was offered to 3,627 employees of a large corporation in Pennsylvania and Delaware. The examination was available to women employees or employee spouses aged 35 years and older. Women were charged $30 for a standard two-view examination. They also received health education materials on mammography and breast self-examination. The remaining costs of the program were underwritten by the corporation. During this program, 3,627 mammographic studies were performed; 63 biopsies were recommended. Fifty-seven biopsies were performed, and nine cancers were diagnosed. Costs of this program are presented in detail. The authors conclude that mobile screening programs at the work site provide an inexpensive, convenient alternative to more traditional screening programs. The inherent advantages of this program are the low cost, the relative ease with which the examination can be performed, and the positive role that corporate medical personnel assume in encouraging individual and group participation.

Entities:  

Mesh:

Year:  1991        PMID: 2006259     DOI: 10.1148/radiology.179.1.2006259

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Multistrategy health education program to increase mammography use among women ages 65 and older.

Authors:  B K Rimer; N Resch; E King; E Ross; C Lerman; A Boyce; H Kessler; P F Engstrom
Journal:  Public Health Rep       Date:  1992 Jul-Aug       Impact factor: 2.792

2.  Redesigning primary care processes to improve the offering of mammography. The use of clinic protocols by nonphysicians.

Authors:  B D McCarthy; M U Yood; M B Bolton; E A Boohaker; C H MacWilliam; M J Young
Journal:  J Gen Intern Med       Date:  1997-06       Impact factor: 5.128

3.  Promoting participation in breast cancer screening.

Authors:  J G Zapka
Journal:  Am J Public Health       Date:  1994-01       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.